Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 mars 2025 03h00 HE | Source: Alvotech

Alvotech kaupir þróunarstarfsemi líftæknifyrirtækisins Xbrane í Svíþjóð

Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hafi keypt þróunarstarfsemi sænska líftæknifyrirtækisins Xbrane Biopharma AB (“Xbrane”). Með kaupunum eykur Alvotech afkastagetu sína í þróun...
20 mars 2025 03h00 HE | Source: Alvotech

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma...